These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17196070)

  • 1. Immediate switching from moclobemide to duloxetine may induce serotonin syndrome.
    Jimenez-Genchi A
    J Clin Psychiatry; 2006 Nov; 67(11):1821-2. PubMed ID: 17196070
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin syndrome induced by duloxetine.
    Hadikusumo B; Ng B
    Aust N Z J Psychiatry; 2009 Jun; 43(6):581-2. PubMed ID: 19452666
    [No Abstract]   [Full Text] [Related]  

  • 3. Serotonin syndrome precipitated by linezolid in a medically ill patient on duloxetine.
    Strouse TB; Kerrihard TN; Forscher CA; Zakowski P
    J Clin Psychopharmacol; 2006 Dec; 26(6):681-3. PubMed ID: 17110838
    [No Abstract]   [Full Text] [Related]  

  • 4. Burning paresthesia related to duloxetine therapy.
    Woo YS; Bahk WM
    J Clin Psychopharmacol; 2014 Jun; 34(3):392-4. PubMed ID: 24633002
    [No Abstract]   [Full Text] [Related]  

  • 5. Duloxetine--three birds with one stone?
    Michel MC
    Int J Clin Pract; 2007 Aug; 61(8):1247-8. PubMed ID: 17627705
    [No Abstract]   [Full Text] [Related]  

  • 6. Digging for data on harms in duloxetine trials.
    Doshi P; Zito J; dosReis S
    BMJ; 2014 Jun; 348():g3578. PubMed ID: 24904123
    [No Abstract]   [Full Text] [Related]  

  • 7. Bleeding gums: duloxetine may be the cause.
    Balhara Y; Sagar R; Varghese ST
    J Postgrad Med; 2007; 53(1):44-5. PubMed ID: 17244971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The serotoninergic syndrome: moclobemide and citalopram].
    Gumà M; Clemente F; Segura A; Costa J
    Med Clin (Barc); 1999 Nov; 113(17):677-8. PubMed ID: 10618787
    [No Abstract]   [Full Text] [Related]  

  • 9. Moclobemide and the risk of serotonin toxicity (or serotonin syndrome).
    Gillman K
    CNS Drug Rev; 2004; 10(1):83-5; author reply 86-8. PubMed ID: 15046013
    [No Abstract]   [Full Text] [Related]  

  • 10. [Life-threatening serotonin syndrome following a single dose of a serotonin reuptake inhibitor during maintenance therapy with a monoamine oxidase inhibitor].
    Güzelcan Y; Kleinpenning AS
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1748; author reply 1748-9. PubMed ID: 16927475
    [No Abstract]   [Full Text] [Related]  

  • 11. A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode.
    Martinez JM; Katon W; Greist JH; Kroenke K; Thase ME; Meyers AL; Edwards SE; Marangell LB; Shoemaker S; Swindle R
    Int Clin Psychopharmacol; 2012 Jan; 27(1):17-26. PubMed ID: 22027844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of paroxetine and rasagiline induces serotonin syndrome in a parkinsonian patient.
    Hébant B; Guillaume M; Desbordes M; Gaillon G; Maltête D; Lefaucheur R
    Rev Neurol (Paris); 2016 Dec; 172(12):788-789. PubMed ID: 27838092
    [No Abstract]   [Full Text] [Related]  

  • 13. Manic switching in patients receiving duloxetine.
    de Dios C; Ezquiaga E
    Am J Psychiatry; 2007 Jul; 164(7):1121. PubMed ID: 17606669
    [No Abstract]   [Full Text] [Related]  

  • 14. The serotonin syndrome.
    Boyer EW; Shannon M
    N Engl J Med; 2005 Mar; 352(11):1112-20. PubMed ID: 15784664
    [No Abstract]   [Full Text] [Related]  

  • 15. Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder.
    Hunziker ME; Suehs BT; Bettinger TL; Crismon ML
    Clin Ther; 2005 Aug; 27(8):1126-43. PubMed ID: 16199241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin syndrome--clomipramine too soon after moclobemide?
    Gillman PK
    Int Clin Psychopharmacol; 1997 Nov; 12(6):339-42. PubMed ID: 9547136
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of serotonin syndrome precipitated by fentanyl and ondansetron in a patient receiving paroxetine, duloxetine, and bupropion.
    Gollapudy S; Kumar V; Dhamee MS
    J Clin Anesth; 2012 May; 24(3):251-2. PubMed ID: 22537574
    [No Abstract]   [Full Text] [Related]  

  • 18. Serotonin syndrome after discontinuation of olanzapine in a combined treatment with duloxetine -- case report.
    Himmighoffen H; Seifritz E; Boeker H
    Pharmacopsychiatry; 2011 Mar; 44(2):75-6. PubMed ID: 21161885
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serotonin syndrome--a case account].
    Zivanović O; Till E
    Med Pregl; 1992; 45(3-4):116-8. PubMed ID: 16104086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine-induced cutaneous adverse reaction.
    Oulis P; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kouzoupis AV; Soldatos CR
    J Clin Psychopharmacol; 2008 Feb; 28(1):104-5. PubMed ID: 18204353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.